GM1 Prophylaxis for Nab-paclitaxel-associated Chemotherapy-induced Peripheral Neuropathy (CIPN) in Patients With Breast Cancer

Abroad (travel likely)RecruitingPHASE3

Conditions

Chemotherapy-induced Peripheral Neuropathy (CIPN)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The Fifth Medical Center of the Chinese People's Liberation Army General Hospital, Beijing, China
Contact: Study coordinator (ZeFei Jiang, PHD) · jzf-cscobc@csco.org.cn · 010-66947175

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Analgesic Efficacy and Safety of Topical VMD-3866 Gel in Management of Pain Induced by Chemotherapy (CIPN)

Chemotherapy-induced Peripheral Neuropathy · Drug-Induced Nephropathy

Abroad (travel likely)RecruitingPHASE2

London, United Kingdom

Safety, Tolerability, and PK of AH-008 Following Single Ascending Dose in Healthy Subjects

Chemotherapy-induced Peripheral Neuropathy (CIPN)

Abroad (travel likely)RecruitingPHASE1

Salt Lake City, United States

Trial of a Virtual Exercise-based Rehabilitation Program to Treat Persistent Chemotherapy-Induced Peripheral Neuropathy (CIPN)

Chemotherapy-induced Peripheral Neuropathy (CIPN)

Abroad (travel likely)RecruitingPHASE3

Toronto, Canada

Scrambler Therapy for Chemotherapy-Induced Peripheral Neuropathy

Chemotherapy-induced Peripheral Neuropathy · CIPN - Chemotherapy-Induced Peripheral Neuropathy

Abroad (travel likely)Recruiting

Cleveland, United States